thisdrug what a medicine's name tells you

WHO naming stem · suffix · 20 listed names

-brutinib

agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitors

WHO's definition, quoted as written in the 2024 stem book
Names only. This page is about -brutinib as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -brutinib. So the letters brutinib sit at the end of the name (…brutinib).

All 20 names WHO lists under -brutinib

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

  1. acalabrutinib
  2. atuzabrutinib
  3. branebrutinib
  4. edralbrutinib
  5. elsubrutinib
  6. evobrutinib
  7. fenebrutinib
  8. ibrutinib
  9. milrebrutinib
  10. nemtabrutinib
  11. orelabrutinib
  12. pirtobrutinib
  13. remibrutinib
  14. rilzabrutinib
  15. sofnobrutinib
  16. spebrutinib
  17. tirabrutinib
  18. tolebrutinib
  19. vecabrutinib
  20. zanubrutinib

Decode another name

Decoded

ibrutinib

Listed INNCarries 2 WHO stems, most specific first: -brutinib …

  • -brutinibend of the nameWHO lists it hereWHO definition: agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitors
  • -tinibend of the nameWHO lists it hereWHO definition: tyrosine kinase inhibitors

“ibrutinib” is an INN that WHO lists under -brutinib, -tinib in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -brutinib (Part II B) and the 20 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.